Buprenorphine Transdermal Patch Generics - Manufacturers & Suppliers
Butrans(US)
| Product/Composition:- | Buprenorphine Transdermal Patch |
|---|---|
| Strength:- | 5 mcg/hr, 10 mcg/hr, 15 mcg/hr, 20 mcg/hr |
| Form:- | Transdermal Patch |
| Reference Brands:- | Butrans(US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Buprenorphine transdermal patches activate mu-opioid receptors, blocking pain signals and altering pain perception for sustained relief. Benefits include long-lasting, effective pain control, improved patient adherence due to convenience, and a lower risk of overdose compared to other opioids when used responsibly and monitored carefully.
Buprenorphine transdermal patches are approved in both the EU and US for managing severe pain. In the EU, brands like Butrans are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and rigorous manufacturing standards. In the US, FDA approval is based on extensive clinical data; generics are also available. Both regions enforce strict regulations, including prescribing controls and pharmacovigilance due to the potential for abuse. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for buprenorphine patches, ensuring adherence to European and American standards for safe, effective pain management in opioid-tolerant patients.